As of 2023, Brazil experienced a mortality figure due to bladder malignant neoplasms standing in the lower thousands. From 2024 to 2028, the forecasted data indicates a steady year-on-year increase in deaths, from 5.17 thousand in 2024 to 5.65 thousand in 2028, with an average annual growth rate (CAGR) signaling a rising trend over these five years.

Future trends to watch for in this domain include:

Improvements in early detection and treatment methods that may curtail mortality rates.
Public health interventions and policies aimed at reducing risk factors associated with bladder cancer.
Potential demographic shifts and healthcare accessibility impacting mortality rates.